The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Globus Medical, Inc. (NYSE:GMED) is one of the cheap robotics stocks to buy right now. On May 18, Citizens reiterated a Market Perform rating on Globus Medical (NYSE:GMED) on first-quarter results exceeding expectations.

The impressive results were characterized by 27% overall revenue growth and record earnings. Organic revenue was up 13%, driven by share gains and procedural volume strength in core spine. Consequently, worldwide revenues totaled $759.9 million, as base business net sales excluding Nevro totaled $677.2 million.

Robust revenue growth came as Globus Medical’s Musculoskeletal Solutions and Enabling Tech segments achieved broad-based growth in the quarter. Revenue in the Spine channel was up 10%, marking the third consecutive quarter of 10% growth. Net income in the quarter totaled $124.3 million as diluted earnings per share increased 64.7% to $1.12.

Earnings beat estimates by 22%, driven by higher sales. International Spine revenue was also up by 10%. For the full year, Globus Medical expects revenue to range between $3.18 billion and $3.33 billion. It has also updated its non-GAAP diluted EPS to between $4.70 and $4.80, up from the previous guidance of $4.40 to $4.50.

Globus Medical, Inc. (NYSE:GMED) develops advanced surgical robotics and navigation platforms designed to improve the accuracy, safety, and efficiency of orthopedic, spinal, and cranial procedures. Their technology acts as a “third hand” for surgeons, combining rigid robotic arms with real-time tracking.

While we acknowledge the potential of GMED as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Sin Stocks to Buy Now and 8 Best CBD Stocks to Buy Right Now.

Disclosure: None. Follow Insider Monkey on Google News.